Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents
- 1 March 2010
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 18 (5), 1899-1909
- https://doi.org/10.1016/j.bmc.2010.01.037
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-dionesBioorganic & Medicinal Chemistry, 2007
- Novel Lavendamycin Analogues as Potent HIV-Reverse Transcriptase Inhibitors: Synthesis and Evaluation of Anti-Reverse Transcriptase Activity of Amide and Ester Analogues of LavendamycinJournal of Medicinal Chemistry, 2003
- Indolequinone Antitumor Agents: Correlation between Quinone Structure, Rate of Metabolism by Recombinant Human NAD(P)H:Quinone Oxidoreductase, and in Vitro CytotoxicityJournal of Medicinal Chemistry, 1998
- Immunological Quantitation of DT‐Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers: Advanced Tumors Express Greater Levels of DT‐DiaphoraseJapanese Journal of Cancer Research, 1998
- Chemistry of Quinoline-5,8-dionesThe Journal of Organic Chemistry, 1998
- Highly Efficient and Practical Syntheses of Lavendamycin Methyl Ester and Related Novel QuinolindionesThe Journal of Organic Chemistry, 1996
- Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxiaEuropean Journal of Cancer, 1994
- β‐Carbolines derived from β‐methyltryptophan and a stereoselective synthesis of (2RS,3SR)‐β‐methyltryptophan methyl esterJournal of Heterocyclic Chemistry, 1988
- Streptonigrin biosynthesis. 8. Evidence for the involvement of a new shikimate pathway product and a new route to quinolinesJournal of the American Chemical Society, 1987
- The Synthesis of the 2-Amino-3-(3-indolyl)-butyric Acids (β-Methyltryptophans)Journal of the American Chemical Society, 1957